Adalimumab for the Treatment of Pityriasis Rubra Pilaris: A Case Report

被引:0
|
作者
Wassef, Cindy [1 ]
Lombardi, Adriana [2 ]
Rao, Babar K. [3 ]
机构
[1] UMDNJ New Jersey Med Sch, Newark, NJ USA
[2] New York Med Coll, Dept Dermatol, New York, NY USA
[3] Robert Wood Johnson Med Sch, Dept Dermatol, Somerset, NJ USA
来源
CUTIS | 2012年 / 90卷 / 05期
关键词
INFLIXIMAB; ETANERCEPT; THERAPY;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Pityriasis rubra pilaris (PRP) is a chronic papulosquamous eruption of the skin characterized by follicular hyperkeratosis, salmon pink scaly plaques with islands of unaffected skin, and palmoplantar keratoderma. Widely used oral systemic and topical treatments are not greatly effective. We present a 62-year-old man with PRP of 2 years' duration who used routine topical treatments, oral retinoids, and UV therapy without improvement, but his symptoms greatly improved with the initiation of adalimumab. Cutis. 2012;90:244-247.
引用
收藏
页码:244 / 247
页数:4
相关论文
共 50 条